{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:24:58Z","timestamp":1762521898342},"reference-count":16,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.6176","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T22:08:31Z","timestamp":1462054111000},"page":"1219-1222","source":"Crossref","is-referenced-by-count":3,"title":["Neurocysticercosis with Diplopia Responds Well to Albendazole"],"prefix":"10.2169","volume":"55","author":[{"given":"Akihiro","family":"Sato","sequence":"first","affiliation":[{"name":"Department of Infection Prevention and Control, Tokyo Medical University Hospital, Japan"},{"name":"Department of Infection Prevention and Control, Tokyo Medical University Hachioji Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itaru","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Infection Prevention and Control, Tokyo Medical University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Infection Prevention and Control, Tokyo Medical University Hospital, Japan"},{"name":"Department of Microbiology, Tokyo Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Fukushima","sequence":"additional","affiliation":[{"name":"Department of Infection Prevention and Control, Tokyo Medical University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutaka","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Department of Infection Prevention and Control, Tokyo Medical University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Infection Prevention and Control, Tokyo Medical University Hachioji Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Tokyo Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Nash TE, Garcia HH. Diagnosis and treatment of neurocysticercosis. Nat Rev Neurol 7: 584-594, 2011.","DOI":"10.1038\/nrneurol.2011.135"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Carabin H, Ndimubanzi PC, Budke CM, et al. Clinical manifestations associated with neurocysticercosis: a systematic review. PLoS Negl Trop Dis 5: e1152, 2011.","DOI":"10.1371\/journal.pntd.0001152"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. DeGiorgio CM, Medina MT, Durón R, Zee C, Escueta SP. Neurocysticercosis. Epilepsy Curr 4: 107-111, 2004.","DOI":"10.1111\/j.1535-7597.2004.43008.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Del Brutto OH. Neurocysticercosis among international travelers to disease-endemic areas. J Travel Med 19: 112-117, 2012.","DOI":"10.1111\/j.1708-8305.2011.00592.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Del Brutto OH, Rajshekhar V, White AC Jr, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology 57: 177-183, 2001.","DOI":"10.1212\/WNL.57.2.177"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Fleury A, Escobar A, Fragoso G, Sciutto E, Larralde C. Clinical heterogeneity of human neurocysticercosis results from complex interactions among parasite, host and environmental factors. Trans R Soc Trop Med Hyg 104: 243-250, 2010.","DOI":"10.1016\/j.trstmh.2010.01.005"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Takayanagui OM, Odashima NS. Clinical aspects of neurocysticercosis. Parasitol Int 55 (Suppl): S111-S115, 2006.","DOI":"10.1016\/j.parint.2005.11.016"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Keane JR. Neuro-ophthalmologic signs and symptoms of cysticercosis. Arch Ophthalmol 100: 1445-1448, 1982.","DOI":"10.1001\/archopht.1982.01030040423010"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kobayashi K, Nakamura-Uchiyama F, Nishiguchi T, et al. Rare case of disseminated cysticercosis and taeniasis in a Japanese traveler after returning from India. Am J Trop Med Hyg 89: 58-62, 2013.","DOI":"10.4269\/ajtmh.12-0355"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Giordani MT, Tamarozzi F, Cattaneo F, Brunetti E. Three cases of imported neurocysticercosis in Northern Italy. J Travel Med 21: 17-23, 2014.","DOI":"10.1111\/jtm.12066"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Yamasaki H, Nagase T, Kiyoshige Y, et al. A case of intramuscular cysticercosis diagnosed definitively by mitochondrial DNA analysis of extremely calcified cysts. Parasitol Int 55: 127-130, 2006.","DOI":"10.1016\/j.parint.2005.11.057"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Carpio A, Kelvin EA, Bagiella E, et al. Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry 79: 1050-1055, 2008.","DOI":"10.1136\/jnnp.2008.144899"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Garcia HH, Pretell EJ, Gilman RH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 350: 249-258, 2004.","DOI":"10.1056\/NEJMoa031294"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Abba K, Ramaratnam S, Ranganathan LN. Anthelmintics for people with neurocysticercosis. Cochrane Database Syst Rev CD000215, 2010.","DOI":"10.1002\/14651858.CD000215.pub3"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. García HH, Evans CA, Nash TE, et al. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev 15: 747-756, 2002.","DOI":"10.1128\/CMR.15.4.747-756.2002"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Takayanagui OM, Odashima NS, Bonato PS, Lima JE, Lanchote VL. Medical management of neurocysticercosis. Expert Opin Pharmacother 12: 2845-2856, 2011.","DOI":"10.1517\/14656566.2011.634801"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/9\/55_55.6176\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T06:01:59Z","timestamp":1567836119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/9\/55_55.6176\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.6176","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}